mAbs for the masses

Harbour: Small A round enough to compete with transgenic mouse platform

mAbs for the masses

Even though Harbour Antibodies B.V. is one of at least three biotechs seeking to broadly out-license their transgenic mouse platforms, Atlas Venture was attracted to the deal because the small investment gives the VC

Read the full 378 word article

How to gain access

Continue reading with a
two-week free trial.